Skip to content

Released Aug 7, 2018, before the open

10-Q filed Aug 7, 2018, 38 days after period end · 0001144204-18-042231

Q2 2018 · 10-Q
Revenue$0.00— vs Q2 2017−100.0% vs Q1 2018
Net Income-$3.26MN/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.15N/M vs Q2 2017N/M vs Q1 2018
Operating Income-$3,164,409N/M
Operating Cash Flowderived-$2,740,125N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2018Q2 2017Q2 2016Q2 2015
Revenue$0.00$0.00——
Net Income-$3.26M-$6.09M-$5.76M-$4.25M
EPS Diluted-$0.15-$0.31-$0.32-$0.26

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR